These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 5374117

  • 1. Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
    Laursen B, Gormsen J.
    Scand J Haematol; 1969; 6(6):402-8. PubMed ID: 5374117
    [No Abstract] [Full Text] [Related]

  • 2. Fibrinolytic activity and haemagglutination inhibition immunoassays.
    Gormsen J.
    Scand J Haematol; 1970; 7(4):261-73. PubMed ID: 4991073
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Blood-aqueous barrier changes during activation of fibrinolysis in plasma].
    Rudobielski R.
    Klin Oczna; 1974 Feb; 44(2):129-33. PubMed ID: 4453093
    [No Abstract] [Full Text] [Related]

  • 8. Immunoelectrophoretic characterization of plasma fibrinogen derivatives in patients with pathological plasma proteolysis.
    Fisher S, Fletcher AP, Alkjaersig N, Sherry S.
    J Lab Clin Med; 1967 Dec; 70(6):903-22. PubMed ID: 4228698
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical experience with an antilipemic agent, ethylchlorophenoxyisobutyrate].
    Noleto PA, de Bulhões F, Tuma M.
    Rev Bras Med; 1969 Oct; 26(10):602-5. PubMed ID: 5404870
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effects of phenphormin on blood fibrinolysis in diabetes mellitus.
    Fiaschi E, Barbui T, Previato G, Di Luzio V, Guarnieri GF, Todesco S.
    Arzneimittelforschung; 1969 Apr; 19(4):638-40. PubMed ID: 5819165
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacological fibrinolysis in occlusive vascular disease and its relation to diabetes mellitus.
    Fearnley GR.
    Postgrad Med J; 1969 May; 45():52-62. PubMed ID: 5364315
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.